Lawrence Liu

1.6k total citations
40 papers, 414 citations indexed

About

Lawrence Liu is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Lawrence Liu has authored 40 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Lawrence Liu's work include Multiple Myeloma Research and Treatments (9 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Lawrence Liu is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Lawrence Liu collaborates with scholars based in United States, France and Belgium. Lawrence Liu's co-authors include Brendan M. McGuire, Manish Thapar, Charles Parker, Ashwani K. Singal, Amrita Krishnan, Joseph A. Odin, Lihui Qin, Joseph R. Bloomer, Makiko Yasuda and Karl E. Anderson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lawrence Liu

38 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Liu United States 10 207 80 69 62 54 40 414
Masayuki Endo Japan 9 109 0.5× 44 0.6× 50 0.7× 46 0.7× 31 0.6× 20 323
Pascale Trioche France 11 95 0.5× 67 0.8× 70 1.0× 15 0.2× 30 0.6× 27 453
Masaya Yamato Japan 10 174 0.8× 14 0.2× 91 1.3× 47 0.8× 43 0.8× 34 459
Francesca Romana Stefani Italy 10 110 0.5× 29 0.4× 26 0.4× 66 1.1× 47 0.9× 15 342
Chengguo Wei United States 11 74 0.4× 25 0.3× 31 0.4× 19 0.3× 39 0.7× 18 263
A Hartmann Brazil 12 118 0.6× 41 0.5× 17 0.2× 70 1.1× 90 1.7× 42 374
Risa Tanaka Japan 14 134 0.6× 78 1.0× 10 0.1× 211 3.4× 106 2.0× 52 528
İnci Yıldız Türkiye 13 160 0.8× 51 0.6× 55 0.8× 68 1.1× 25 0.5× 37 383
Henning Feist Germany 11 237 1.1× 158 2.0× 46 0.7× 187 3.0× 45 0.8× 30 572

Countries citing papers authored by Lawrence Liu

Since Specialization
Citations

This map shows the geographic impact of Lawrence Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Liu more than expected).

Fields of papers citing papers by Lawrence Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Liu. The network helps show where Lawrence Liu may publish in the future.

Co-authorship network of co-authors of Lawrence Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Liu. A scholar is included among the top collaborators of Lawrence Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Liu. Lawrence Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaud, Tzeyu L., Mei Wang, Daphne R. Friedman, et al.. (2025). Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study. Journal of the American Heart Association. 15(1). e042187–e042187. 1 indexed citations
2.
Liu, Lawrence & Myo Htut. (2025). Chimeric antigen receptor T-cell therapy for multiple myeloma. Current Opinion in Oncology. 37(5). 499–505.
3.
Liu, Lawrence, Jesper Lykke Jacobsen, & Hubert Saleur. (2025). Emerging Jordan blocks in the two-dimensional Potts and loop models at generic Q. Journal of High Energy Physics. 2025(2). 1 indexed citations
4.
Liu, Lawrence, Byron Sigel, Mei Wang, et al.. (2024). Uncontrolled diabetes mellitus and the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans.. Journal of Clinical Oncology. 42(16_suppl). 7551–7551. 1 indexed citations
5.
Woo, Jennifer S., et al.. (2024). Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapy. Seminars in Hematology. 61(5). 273–283. 1 indexed citations
6.
Liu, Lawrence, et al.. (2023). Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder. SHILAP Revista de lepidopterología. 4(3). 848–851. 2 indexed citations
7.
Liu, Lawrence, et al.. (2023). A quantitative framework for patient‐specific collision detection in proton therapy. Journal of Applied Clinical Medical Physics. 25(4). e14247–e14247. 1 indexed citations
8.
Liu, Lawrence & Amrita Krishnan. (2023). Talquetamab in multiple myeloma. Haematologica. 109(3). 718–724. 21 indexed citations
9.
10.
Liu, Lawrence, et al.. (2022). Self-reporting of Conflicts of Interest by Ophthalmology Researchers Compared with the Open Payments Database Industry Reports. Ophthalmology. 130(4). 387–393. 4 indexed citations
11.
Kaderka, Robert, et al.. (2022). Toward automatic beam angle selection for pencil‐beam scanning proton liver treatments: A deep learning–based approach. Medical Physics. 49(7). 4293–4304. 7 indexed citations
12.
Liu, Lawrence, Feng Gao, Ramzi Abboud, et al.. (2022). Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality. Transplantation and Cellular Therapy. 28(8). 510.e1–510.e9. 29 indexed citations
13.
Liu, Lawrence, et al.. (2021). Isatuximab for the treatment of multiple myeloma. Drugs of today. 57(11). 665–665. 1 indexed citations
14.
Giebeler, Annelise, et al.. (2021). Double-strand breaks measured along a 160 MeV proton Bragg curve using a novel FIESTA-DNA probe in a cell-free environment. Physics in Medicine and Biology. 66(5). 54001–54001. 1 indexed citations
15.
Ear, Jason, Ying Dunkel, Yash Mittal, et al.. (2019). Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors. Scientific Reports. 9(1). 12124–12124. 7 indexed citations
16.
Bichoupan, Kian, Valérie Martel‐Laferrière, David Sachs, et al.. (2014). Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology. 60(4). 1187–1195. 30 indexed citations
17.
18.
Liu, Lawrence, Lihui Qin, & A. S. Knisely. (2010). A Patient with Persistent Pruritus. Seminars in Liver Disease. 30(2). 205–209. 1 indexed citations
19.
Massoumi, Hatef, Hussien Elsiesy, Brent M. Peterson, et al.. (2009). An Escalating Dose Regimen of Pegylated Interferon and Ribavirin in HCV Cirrhotic Patients Referred for Liver Transplant. Transplantation. 88(5). 729–735. 11 indexed citations
20.
Ward, Stephen, et al.. (2008). Cholestatic Liver Injury Associated with Whey Protein and Creatine Supplements. Seminars in Liver Disease. 28(2). 226–231. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Endo Breakdown of academic impact, for papers by Pascale Trioche Breakdown of academic impact, for papers by Masaya Yamato Breakdown of academic impact, for papers by Francesca Romana Stefani Breakdown of academic impact, for papers by Chengguo Wei Breakdown of academic impact, for papers by A Hartmann Breakdown of academic impact, for papers by Risa Tanaka Breakdown of academic impact, for papers by İnci Yıldız Breakdown of academic impact, for papers by Henning Feist
Rankless by CCL
2026